[pending] TAVABOROLE (TAVABOROLE)
Pending LLM rewrite. Source: FDA_DRUG D-0595-2025.
- Product
- TAVABOROLE — TAVABOROLE (TAVABOROLE)
- Category
- Drug
- Distribution
- Distributed nationwide
Category
FDA recalls of prescription and over-the-counter drugs.
FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.
The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.
If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.
Pending LLM rewrite. Source: FDA_DRUG D-0595-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0590-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0593-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0589-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0591-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0580-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0579-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0575-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0578-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0582-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0588-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0581-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0577-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0584-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0583-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0576-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0585-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0587-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0586-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0574-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0571-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0573-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0568-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0561-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0565-2025.
Looking for a different category? Browse all recalls.